不同病因肝衰竭患者外周血单个核细胞HLA-DR基因水平及血Th17和CD4+CD25+Treg细胞百分比的变化

doi:10.3969/.j.issn.1672-5069.2015.06.009

摘要/Abstract

摘要： 目的探讨不同病因所致肝衰竭患者外周血单个核细胞（PBMCs）HLA-DR mRNA及Th17和CD4⁺CD25⁺Treg细胞水平的变化及其意义。方法本研究纳入肝衰竭患者50例,其中乙型肝炎肝衰竭15例,药物性肝损伤12例,酒精性肝病13例,自身免疫性肝炎10例;慢性乙型肝炎患者17例和正常人10例。采用PCR法检测PBMCs中HLA-DR mRNA水平,使用流式细胞仪检测CD4⁺CD25⁺Treg和Th17细胞百分比。结果乙型肝炎肝衰竭患者HLA-DR mRNA水平为（134.5±15.2）,显著高于药物性肝损伤组的（17.9±1.2）、酒精性肝病组的（19.6±2.0）和自身免疫性肝炎组的[（11.2±1.2）,P<0.05];不同病因肝衰竭患者Th17和CD4⁺CD25⁺Treg细胞百分比[分别为（4.4±0.6）%和（3.9±0.6）%左右]的差异无统计学意义（P>0.05）,但与慢性乙型肝炎[分别为（3.7±0.2）%和（6.1±0.4）%和正常人（2.1±0.7）%和（7.0±0.9）%比,均有显著性差异（P<0.05）;对不同病因肝衰竭患者进行动态观察发现,19例死亡患者CD4⁺CD25⁺Treg细胞百分比呈持续下降,直至死亡,而31例生存患者则逐渐恢复至接近正常水平。结论外周血单个核细胞HLA-DR mRNA水平及Th17和CD4⁺CD25⁺Treg细胞百分比的变化与肝衰竭患者的病情密切相关,可作为判断肝衰竭严重程度及预后的指标。

关键词: 肝衰竭, HLA-DR, Th17细胞, CD4+CD25+Treg细胞

Abstract: ObjectiveTo investigate the changes of HLA-DR mRNA,and Th17 and CD4⁺CD25⁺Treg cells in peripheral blood mononuclear cells（PBMCs） in patients with liver failure. Methods HLA-DR mRNA was detected by PCR,and Th17 and CD4⁺CD25⁺Treg cells were measured by flow cytometry in 50 patients with liver failure,including 15 arisen from hepatitis B,12 from drug-induced liver injury（DILI）,13 from alcoholic liver diseases,and 10 from autoimmune liver diseases,and in 17 patients with chronic hepatitis B and 10 healthy persons. Results The HLA-DR mRNA levels in PBMCs in patients with hepatitis B-induced liver failure was（134.5±15.2）,much higher than （17.9±1.2）in DILI-,（19.6±2.0）in alcoholic and[（11.2±1.2）,P<0.05] in autoimmune liver disease-induced liver failure;the percentages of Th17 cells and CD4⁺CD25⁺Treg cells [（4.4±0.6）% and（3.9±0.6）% or less,respectively] in patients with different etiologic liver failures were not significantly different（P>0.05）,while there were a significant difference as compared to（3.7±0.2）% and（6.1±0.4）% in patients with chronic hepatitis B or（2.1±0.7）% and（7.0±0.9）% in normal control （P<0.05）;the percentages of CD4⁺CD25⁺Treg cells in 19 died patients decreased gradually,while it increased gradually in 31 survived patients. Conclusion The HLA-DR mRNA levels and CD4⁺CD25⁺Treg cells are closely related to the illness severity of patients with liver failure,and they may be used as parameters to estimate the clinical prognosis.

Key words: Liver failure, HLA-DR, Th17 cells, CD4+CD25+Treg cells

刘晶晶，李庆彦，刘春华. 不同病因肝衰竭患者外周血单个核细胞HLA-DR基因水平及血Th17和CD4⁺CD25⁺Treg细胞百分比的变化[J]. 实用肝脏病杂志, 2015, 18(6): 598-602.

Liu Jingjing， Li Qingyan， Liu Chunhua.. HLA-DR mRNA levels,Th17 and CD4⁺CD25⁺Treg cell percentages in peripheral blood mononuclear cells in patients with liver failure[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 598-602.

参考文献

[1] 李梦东,聂青和.肝衰竭的研究现状与进展.实用肝脏病杂志,2013,16（1）：9-11.
[2] Wasmuth H E,Kunz D,Yagmur E,et al.Patients with acute on chronic liver failure display“sepsis-like” immune paralysis.J Hepatol,2005,42（2）:195-201.
[3] 中华医学会感染病学分会肝衰竭与人工肝学组和肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南.实用肝脏病杂志,2013,16（3）：210-216.
[4] 中华医学会.病毒性肝炎防治方案.中华传染病杂志,2001,19（1）：56- 62.
[5] Berry PA,Antoniades CG,Carey I,et al.Severity of the compensatory anti-inflammatory response determined by monocyte HLA-DR expression may assist outcome prediction in cirrhosis. Inten Care Med, 2011, 37（3）:453-460.
[6] Abeles RD,McPhail MJ,Sowter D,et al. CD14,CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14（hi）/CD16（neg） monocytes: Expansion of CD14（hi） /CD16（pos） and contraction of CD14（lo） /CD16（pos） monocytes in acute liver failure. Cytometry,2012,81（10）:823-834.
[7] Volk HD,Reinke P,Krausch D,et al.Monocyte deactivation rationale for a new therapeutic stratery in sepsis.Inten Care Med,1996（Suppl 4）,22：s474-s481.
[8] 蔡莉芬,孙梅花,王立静,等. EV71 感染手足口病患儿外周血检测Treg 细胞、Th17 细胞、TGF-β、IL-17A 的临床意义. 河北医药,2011,33（8）:1143-1144.
[9] Afzali B,Lombardi G,Lechler RI,et al.The roleo of T helper l7 （Thl7）and regulatory T cells（Treg） in human organ transplantation and autoimmune disease.Clin Exp Immunol,2007,148（1）：32-46.
[10] Bettelli E,Carrier Y,Gao W,et al.Reciprocal developmental pathways for The generation of pathogenic effector THl7 and regulatory T cells. Nature,2006,441（7090）： 235-238.
[11] 吴敏泉, 罗艳, 何艳, 等. HIV感染者Th17和Treg细胞的变化及意义. 中国感染控制杂志,2011, 10（4）: 252-255.
[12] 谭艳芳,于四景,王婕,等. Treg/Th17 平衡在巨细胞病毒感染发病机制中的作用. 细胞与分子免疫学杂志,2012,28（6）：649-651.
[13] 丁爱萍,张瑶,魏恒,等.HPV16型存在状态与Treg/Th17细胞因子的相关性研究.中华医学杂志,2013,93（37）:2957-2960.
[14] 胡月明,马莉,李虹,等.HBV感染者外周血Th17细胞和Treg细胞的检测及意义.检验医学,2014,29（1）:21-25.
[15] 杨莉,孙淑媛,薛庆宵,等. Th17和Treg细胞及相关细胞因子在手足口病患儿外周血中的变化.中华微生物学和免疫学杂志,2014,34（9）:697-701.
[16] 邓勇,余雪平,苏志军,等.淋巴细胞HLA-DR分子表达在重型乙型肝炎中的作用及临床意义.肝脏,2014,19（7）：487-490.
[17] 胡月明,马莉,李虹.HBV感染者外周血Th17细胞和Treg细胞的检测及意义.检验医学,2014,29（1）：21-25.
[18] 刘春华,崔速南,刘靓雯,等.慢性乙型肝炎肝硬化淋巴细胞亚群及HLA-DR抗原的表达.中国现代医学杂志,2010,20（12）:1825-1828.
[19] 王十锦,张蓓,王丽,等.大鼠肝损伤模型中Th17/Treg失衡的研究.免疫学杂志,2014,30（2）：133-138.
[20] 苏磊,孟繁甦,唐柚青,等.创伤脓毒症患者免疫状态监测及乌司他丁联合胸腺肽α1行免疫调理的临床研究. 解放军医学杂志,2008,11（33）：1366-1368.